These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 12535387

  • 1. Vaccines for preventing malaria.
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2003; (1):CD000129. PubMed ID: 12535387
    [Abstract] [Full Text] [Related]

  • 2. WITHDRAWN: Vaccines for preventing malaria.
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2007 Jul 18; 2003(4):CD000129. PubMed ID: 17636596
    [Abstract] [Full Text] [Related]

  • 3. Vaccines for preventing malaria.
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2000 Jul 18; (2):CD000129. PubMed ID: 10796492
    [Abstract] [Full Text] [Related]

  • 4. Vaccines for preventing malaria (SPf66).
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2006 Apr 19; 2006(2):CD005966. PubMed ID: 16625647
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The development of malaria vaccines: SPf66--what next?
    Tanner M, Alonso PL.
    Schweiz Med Wochenschr; 1996 Jul 09; 126(27-28):1210-5. PubMed ID: 8766632
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of SPf66 malaria vaccine efficacy in Brazil.
    Urdaneta M, Prata A, Struchiner CJ, Tosta CE, Tauil P, Boulos M.
    Am J Trop Med Hyg; 1998 Mar 09; 58(3):378-85. PubMed ID: 9546423
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense transmission of Plasmodium falciparum.
    Alonso PL, Smith TA, Armstrong-Schellenberg JR, Kitua AY, Masanja H, Hayes R, Hurt N, Font F, Menendez C, Kilama WL, Tanner M.
    J Infect Dis; 1996 Aug 09; 174(2):367-72. PubMed ID: 8699068
    [Abstract] [Full Text] [Related]

  • 14. Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66.
    Haywood M, Conway DJ, Weiss H, Metzger W, D'Alessandro U, Snounou G, Targett G, Greenwood B.
    Trans R Soc Trop Med Hyg; 1999 Feb 09; 93 Suppl 1():65-8. PubMed ID: 10450429
    [Abstract] [Full Text] [Related]

  • 15. Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria.
    al-Yaman F, Genton B, Anders R, Taraika J, Ginny M, Mellor S, Alpers MP.
    Parasite Immunol; 1995 Sep 09; 17(9):493-501. PubMed ID: 8552419
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.
    Bojang KA, Milligan PJ, Pinder M, Vigneron L, Alloueche A, Kester KE, Ballou WR, Conway DJ, Reece WH, Gothard P, Yamuah L, Delchambre M, Voss G, Greenwood BM, Hill A, McAdam KP, Tornieporth N, Cohen JD, Doherty T, RTS, S Malaria Vaccine Trial Team.
    Lancet; 2001 Dec 08; 358(9297):1927-34. PubMed ID: 11747915
    [Abstract] [Full Text] [Related]

  • 17. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group.
    Nosten F, Luxemburger C, Kyle DE, Ballou WR, Wittes J, Wah E, Chongsuphajaisiddhi T, Gordon DM, White NJ, Sadoff JC, Heppner DG.
    Lancet; 1996 Sep 14; 348(9029):701-7. PubMed ID: 8806288
    [Abstract] [Full Text] [Related]

  • 18. Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children.
    Alonso PL, Lopez MC, Bordmann G, Smith TA, Aponte JJ, Weiss NA, Urassa H, Armstrong-Schellenberg JR, Kitua AY, Masanja H, Thomas MC, Oettli A, Hurt N, Hayes R, Kilama WL, Tanner M.
    Parasite Immunol; 1998 Feb 14; 20(2):63-71. PubMed ID: 9572049
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador.
    Sempértegui F, Estrella B, Moscoso J, Piedrahita L, Hernández D, Gaybor J, Naranjo P, Mancero O, Arias S, Bernal R.
    Vaccine; 1994 Mar 14; 12(4):337-42. PubMed ID: 8178556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.